Home » Topics » Disease categories and therapies » Immune

Immune
RSS

GlaxoSmithKline develops new meningitis vaccine for Africa

Feb. 26, 2003

Active Biotech presents new immunomodulators targeting the CD80/CD28 interaction

Feb. 25, 2003

DOR BioPharma to license intranasal vaccine technology from U.K.'s Ministry of Defence

Feb. 21, 2003

Superior survival compared to Atgam not achieved in GvHD patients treated with ABX-CBL

Feb. 19, 2003

Development of oral botulinum toxin vaccine commences at DOR BioPharma

Feb. 19, 2003

PNA CXCR3 antisense lengthens skin allograft survival in vivo

Feb. 18, 2003

Histone deacetylase inhibitors block T-cell activity and may prevent allograft rejection

Feb. 18, 2003

IkB kinase 2: a potential target for prevention of transplant rejection

Feb. 18, 2003

FluINsure generates encouraging data in challenge study

Feb. 17, 2003

Novel vitamin D analogue with dissociation between immunosuppressive and hypercalcemic effects

Feb. 14, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...